These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9330784)

  • 41. Intestinal drug transporter expression and the impact of grapefruit juice in humans.
    Glaeser H; Bailey DG; Dresser GK; Gregor JC; Schwarz UI; McGrath JS; Jolicoeur E; Lee W; Leake BF; Tirona RG; Kim RB
    Clin Pharmacol Ther; 2007 Mar; 81(3):362-70. PubMed ID: 17215845
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Time-dependent inhibition of histamine-induced cutaneous responses by oral and intramuscular diphenhydramine and oral fexofenadine.
    Jones DH; Romero FA; Casale TB
    Ann Allergy Asthma Immunol; 2008 May; 100(5):452-6. PubMed ID: 18517077
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Significant food interactions observed with a nifedipine modified-release formulation marketed in the European Union.
    Wonnemann M; Schug B; Schmücker K; Brendel E; van Zwieten PA; Blume H
    Int J Clin Pharmacol Ther; 2006 Jan; 44(1):38-48. PubMed ID: 16425970
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In brief: fexofenadine (Allegra) and fruit juice.
    Med Lett Drugs Ther; 2011 May; 53(1365):41. PubMed ID: 21617593
    [No Abstract]   [Full Text] [Related]  

  • 45. Bioequivalence of fexofenadine tablet formulations assessed in healthy Iranian volunteers.
    Valizadeh H; Barghi L; Jalilian H; Islambulchilar Z; Zakeri-Milani P
    Arzneimittelforschung; 2009; 59(7):345-9. PubMed ID: 19728561
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-lasting inhibition of the intestinal absorption of fexofenadine by cyclosporin A in rats.
    Suzuki K; Shitara Y; Fukuda K; Horie T
    J Pharm Sci; 2012 Jul; 101(7):2606-15. PubMed ID: 22538465
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of food on the absorption of oral ziprasidone.
    Miceli JJ; Glue P; Alderman J; Wilner K
    Psychopharmacol Bull; 2007; 40(3):58-68. PubMed ID: 18007569
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Visualization of first-pass drug metabolism of terfenadine by MALDI-imaging mass spectrometry.
    Chen J; Hsieh Y; Knemeyer I; Crossman L; Korfmacher WA
    Drug Metab Lett; 2008 Jan; 2(1):1-4. PubMed ID: 19356062
    [TBL] [Abstract][Full Text] [Related]  

  • 49. How sequential studies inform drug development: evaluating the effect of food intake on optimal bioavailability of ziprasidone.
    Lincoln J; Stewart ME; Preskorn SH
    J Psychiatr Pract; 2010 Mar; 16(2):103-14. PubMed ID: 20511734
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of Garlic, Gingko, and St. John's Wort Extracts on the Pharmacokinetics of Fexofenadine: A Mechanistic Study.
    Turkanovic J; Ward MB; Gerber JP; Milne RW
    Drug Metab Dispos; 2017 May; 45(5):569-575. PubMed ID: 28188296
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of the effect of 3 different diets on the bioavailability of 2 sustained release theophylline matrix tablets.
    Gai MN; Isla A; Andonaegui MT; Thielemann AM; Seitz C
    Int J Clin Pharmacol Ther; 1997 Dec; 35(12):565-71. PubMed ID: 9455715
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Modest effect of impaired P-glycoprotein on the plasma concentrations of fexofenadine, quinidine, and loperamide following oral administration in collies.
    Kitamura Y; Koto H; Matsuura S; Kawabata T; Tsuchiya H; Kusuhara H; Tsujimoto H; Sugiyama Y
    Drug Metab Dispos; 2008 May; 36(5):807-10. PubMed ID: 18299336
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Investigation on modulation of human P-gp by multiple doses of Radix Astragali extract granules using fexofenadine as a phenotyping probe.
    Zhou Q; Ye Z; Ruan Z; Zeng S
    J Ethnopharmacol; 2013 Apr; 146(3):744-9. PubMed ID: 23422332
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of food on the absorption and pharmacokinetics of rivaroxaban.
    Stampfuss J; Kubitza D; Becka M; Mueck W
    Int J Clin Pharmacol Ther; 2013 Jul; 51(7):549-61. PubMed ID: 23458226
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of the antihistamine effects of olopatadine, cetirizine and fexofenadine during a 24 h period: a double-blind, randomized, crossover, placebo-controlled comparison in skin responses induced by histamine iontophoresis.
    Takahashi H; Zhang Y; Morita E
    Arch Dermatol Res; 2008 Jul; 300(6):291-5. PubMed ID: 18305947
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sensitive LC-MS/MS-ESI method for simultaneous determination of montelukast and fexofenadine in human plasma: application to a bioequivalence study.
    Muppavarapu R; Guttikar S; Rajappan M; Kamarajan K; Mullangi R
    Biomed Chromatogr; 2014 Aug; 28(8):1048-56. PubMed ID: 24424850
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Atorvastatin does not produce a clinically significant effect on the pharmacokinetics of terfenadine.
    Stern RH; Smithers JA; Olson SC
    J Clin Pharmacol; 1998 Aug; 38(8):753-7. PubMed ID: 9725552
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Influence of food on the pharmacokinetics of apricitabine, a novel deoxycytidine analogue reverse transcriptase inhibitor.
    Holdich T; Sawyer J
    Expert Opin Pharmacother; 2008 Aug; 9(12):2021-5. PubMed ID: 18671458
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of food on the bioavailability of dolasetron mesylate tablets.
    Lippert C; Keung A; Arumugham T; Eller M; Hahne W; Weir S
    Biopharm Drug Dispos; 1998 Jan; 19(1):17-9. PubMed ID: 9510981
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Preparation and evaluation of fexofenadine microemulsions for intranasal delivery.
    Piao HM; Balakrishnan P; Cho HJ; Kim H; Kim YS; Chung SJ; Shim CK; Kim DD
    Int J Pharm; 2010 Aug; 395(1-2):309-16. PubMed ID: 20635476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.